Physician profile
Robyn Frederick Fallaw
NPI 1477676468
$1,533.42
in general payments reported to CMS, 2019-2025
20 companies · $655 in 2025
The $655 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.53 · 2022: $148 · 2023: $260 · 2024: $442 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,357.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $236.22 | 2022-2025 | Mounjaro, Jardiance |
| Exact Sciences Corporation | $172.41 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $170.13 | 2023-2025 | |
| Pfizer INC. | $138.50 | 2019-2025 | |
| Glaxosmithkline, LLC. | $105.10 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $100.79 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $84.59 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Amgen INC. | $80.28 | 2023-2025 | Repatha, Otezla, Repatha |
| Boston Scientific Corporation | $76.57 | 2022-2025 | General - Tachy |
| Vital Connect, INC | $72.59 | 2025 | Vitalpatch Rtm |
| Abbott Laboratories | $59.74 | 2024-2025 | Freestyle Libre 3 |
| Inari Medical, INC. | $57.06 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $36.75 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.13 | 2023-2024 | Jardiance |
| Corcept Therapeutics | $30.14 | 2025 | Korlym |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $21.73 | 2025 | Clottriever Bold Catheter |
| Medtronic, INC. | $19.66 | 2025 | Intellis Adaptivestim |
| Mylan Specialty L.P. | $18.53 | 2022 | |
| Astellas Pharma US INC | $16.60 | 2025 | Veozah |
| Phathom Pharmaceuticals, INC. | $4.90 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn Fallaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.